Simon Thelwall

Simon Thelwall

Public Health England - London / United Kingdom
Others
AD Scientific Index ID: 4514231
-
person_outline Simon Thelwall's MOST POPULAR ARTICLES
1-) Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variantJL Bernal, N Andrews, C Gower, E Gallagher, R Simmons, S Thelwall, ...New England Journal of Medicine, 202123632021
2-) Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variantN Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard, E Gallagher, ...New England Journal of Medicine 386 (16), 1532-1546, 202219462022
3-) Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) Variants in EnglandT Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ...The Lancet, 202211022022
4-) Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort studyKA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...The Lancet Infectious Diseases 22 (1), 35-42, 20228672022
5-) Duration of protection against mild and severe disease by Covid-19 vaccinesN Andrews, E Tessier, J Stowe, C Gower, F Kirsebom, R Simmons, ...New England Journal of Medicine 386 (4), 340-350, 20226172022